Document:

EXHIBIT 10.16

  

  
    Emergent BioSolutions Inc.

    

    

    Non-Qualified UK Stock Option Award Agreement – UK Participant

    

    

    1. Grant of Option.

    This UK Stock Option Award Agreement  evidences the grant by Emergent BioSolutions Inc., a Delaware
        corporation (the “Company”), to a UK employee of the Company (the “Participant”),
        of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s Stock Incentive Plan (the “Plan”), that number of shares
        (the “Shares”) of common stock, with a $0.001 par value per share, of the Company (“Common Stock”) set forth under the summary of  the grant in your account in the Company’s third-party electronic stock administrative platform (the “Grant Summary”) at the Grant Price identified on the Grant Summary.  Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on the Expiration Date identified on the Grant Summary.

    This option shall not be an incentive stock option as defined in Section 422 of the Internal Revenue
        Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”).  Except as otherwise indicated by the context, the term “Participant”, as
        used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

    The grant of options under the Plan is made at the discretion of the Company and the Plan may be
        suspended or terminated by the Company at any time.

    The Company does not give any advice or any guarantee as to how the grant, vesting or exercise of the
        option will be taxed and the Participant should consult an independent financial adviser in that respect.

    2.  Vesting Schedule.

    This non-qualified stock option shall vest in the aggregate in three equal annual installments on
        the day immediately prior to each anniversary of the grant date.  Specifically, this option shall vest in accordance with the future vesting schedule indicated on the detailed view of the option as viewed under your account in the Company’s
        third-party electronic stock administrative platform.

    The right of exercise shall be cumulative so that to the extent the option is not exercised in any
        period to the maximum extent permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares for which it is vested until the earlier of the Expiration Date or the termination of this option under Section 3 hereof
        or the Plan.

    3.  Form of Exercise.

    Each election to exercise this option shall be in accordance with the Company’s policies and
        procedures.

    The Participant may purchase less than the number of shares covered hereby, provided that no
        partial exercise of this option may be for any fractional share.

    (a)  Continuous Relationship with the Company Required. 
        Except as otherwise provided in this Section 3, this option may not be exercised unless the Participant, at the time he or she exercises this option, is, and has been at all times since the grant date, an employee or director of, the Company or any
        other entity the employees or, directors, of which are eligible to receive option grants under the Plan (an “Eligible Participant”).

    (b)  Termination of Relationship with the Company.  If
        the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (c) and (d) below, the right to exercise this option shall terminate 90 days after such cessation (but in no event after the Expiration
        Date), provided that this option shall be exercisable only to the
        extent that the Participant was entitled to exercise this option on the date of such cessation.  Notwithstanding the foregoing, if the Participant, prior to the Expiration Date, violates the non-competition or confidentiality provisions of any
        employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company, the right to exercise this option shall terminate immediately upon such violation.

    (c) Exercise Period Upon Death or Disability.  If the
        Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Expiration Date while he or she is an Eligible Participant and the Company has not terminated such relationship for “cause” as specified in
        paragraph (d) below, this option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in the case of death by an authorized transferee), provided that this option shall be exercisable only to the extent that this option was
        exercisable by the Participant on the date of his or her death or disability, and further provided that this option shall not be exercisable after the Expiration Date.

    (d)   Termination for Cause.  If, prior to the
        Expiration Date, the Participant’s employment or other relationship with the Company is terminated by the Company for Cause (as defined in the Plan), the right to exercise this option shall terminate immediately upon the effective date of such
        termination of employment or other relationship.

    4.  UK Tax Obligations

    (a) Tax Indemnity. The Participant agrees to indemnify
        and keep indemnified his employing company (the “Employer”) and the Company from and against any liability for or obligation to pay any Tax Liability (a “Tax Liability” being any liability for income tax, employee’s National Insurance contributions and (at the discretion of the Company and where lawful) employer’s
        National Insurance Contributions (or other similar obligations to pay tax and social security wherever in the world arising) that is attributable to: (1) the grant or any benefit derived by Participant from, the grant, vesting or exercise of the
        option or the Shares which are the subject of the option; (2) the transfer or issue of Shares to Participant on exercise of the option; (3) any restrictions applicable to the Shares held by the Participant ceasing to apply to those shares; or (4)
        the disposal of any Shares.

    (b) Tax Liability. The Company will not issue any
        Shares on exercise of this option until the Participant has made such arrangements as the Company may require for the satisfaction of any Tax Liability that may arise in connection with exercise of this option  and/or the acquisition of the Shares
        by the Participant. The Company shall not be required to issue, allot or transfer Shares until Participant has  satisfied this obligation.

    (c) Election. The Participant undertakes that upon
        request by the Company, he/she will (on or within 14 days acquiring the Shares) join with his Employer in electing, pursuant to Section 431(1) of the Income Tax (Earnings and Pensions) Act 2003 (“ITEPA”) that, for relevant tax purposes, the market value of the Shares acquired on exercise of the option on any occasion will be calculated as if the Shares were not restricted and Sections 425 to 430
        (inclusive) of ITEPA are not to apply to such Shares.

    (d) The Company has the right and option, but not the obligation, to  treat the Participant’s failure to provide timely payment in accordance
        with the Plan of any withholding tax arising in connection with the option as the Participant’s election to satisfy all or any portion of the withholding tax by requesting the Company repurchase Shares otherwise issuable under the option on
        exercise limited to the number of Shares which have  an aggregate fair market value on the date of repurchase necessary to pay the aggregate  amount of Tax Liability.

    (e) The Participant acknowledges that the Participant is ultimately liable and responsible for all taxes owed in connection with the option,
        regardless of any action the Company takes with respect to any tax withholding obligations that arise in connection with the option. The Company does not make any representation or undertaking regarding the treatment of any tax withholding in
        connection with the vesting or exercise of the option or the subsequent sale of Shares. The Company does  not commit and is under no obligation to structure the option to reduce or eliminate the Participant’s Tax Liability.

    5.  Nontransferability of Option.

    This option may not be sold, assigned, transferred, pledged or otherwise encumbered by the
        Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, shall be exercisable only by the Participant; provided, however, that the gratuitous
        transfer of this option by the Participant to or for the benefit of any immediate family member, domestic partner, family trust or other entity established for the benefit of the Participant and/or an immediate family member thereof if, with
        respect to such proposed transferee, the Company would be eligible to use a Registration Statement on Form S-8 for the registration of the sale of the Common Stock subject to such option under the Securities Act of 1933, as amended; provided,
        further, that the Company shall not be required to recognize any such transfer until such time as the Participant and such authorized transferee shall, as a condition to such transfer, deliver to the Company a written instrument in form and
        substance satisfactory to the Company confirming that such transferee shall be bound by all of the terms and conditions of the option; and, provided, further, that no option intended to be an incentive stock option shall be transferable unless the
        Board of Directors shall otherwise permit.

    6. Data Protection

    (a) The Participant expressly acknowledges that the Company’s processing of his personal data is necessary:

    i.  for the performance of
        this UK Stock Option  Award Agreement;

    ii.  for the legitimate
        interests of the Company (which includes all the interests noted in Section 6(b) (i)-(vi) below); and/or

    iii.  to comply with the
        Company’s legal obligations in the UK and/or other EU member states in connection with: (a) the Participant’s employment; (b) any litigation, internal or regulatory investigation; or (c) as otherwise permitted by the Data Protection Act 1998or by
        Regulation EU 2016/679 (the “GDPR”).

    

    

    (b) The Participant further acknowledges that the Company’s processing of his sensitive, or special categories of, personal data (which may
        include information relating to health, personal characteristics, criminal offences, allegations of criminal conduct and trade union membership) is necessary:

    
      	
              i. 

            	
              to carry out its or their obligations to the Participant in the fields of employment,
                  social security, and/or social protection;

            

    

    ii.  for the purposes of
        preventative or occupational medicine,  or the assessment of working capacity;

    iii.  for statistical purposes
        and equal opportunities monitoring;

    iv.  to administer its
        pensions and benefits schemes;

    v.  in connection with the
        establishment, exercise or defence of legal claims; and/or

    vi.  for reasons of
        substantial public interest, as further described in the Company’s data protection policy.

    

    

    (c) The processing may include disclosure of personal data and sensitive or special categories of personal data to third parties including
        benefit providers, prospective purchasers or service providers and governmental authorities.

    (d) A separate privacy notice has been provided to you in accordance with article 13 of the GDPR.

    (e) The Participant expressly acknowledges that the Company may transfer such data outside the European Economic Area (including, in particular,
        to offices in the United States) for such purposes and acknowledge that such countries may not have laws which adequately safeguard such data.

    7.  Acknowledgement.

    The Participant acknowledges that this UK  Stock Option Award Agreement has
        not been issued and has not been approved by, an authorised person within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom and is being directed at the Participant because the offer to which this UK Stock Option
        Award Agreement relates has been determined as having regard to the Participant’s circumstances as an employee of the Company. This UK Stock Option Award Agreement is strictly confidential and is not for distribution to, and may not be acted upon
        by, any other person other than the person to whom it has been specifically addressed.

      8. Provisions of the Plan.

    This UK Stock Option Award Agreement is subject to the provisions of the Plan,
        a copy of which is furnished to the Participant with this option.

    

    

    Signed by [●] [Company]

     ______________________________________________________________________

    

    acting by [●]

    Date:__________________________________________________________________

      

    

    

    I hereby agree to accept the grant of the Option on and subject to the terms and conditions set out in the Plan and this UK Stock Option Award
          Agreement.

     _______________________________________________________________________

    

    [●][Name] DateEXHIBIT 10.17

  

  

  

  
    Emergent BioSolutions Inc.

    

    

    Form of UK Restricted Stock Unit Award Agreement – UK Participant

    

    

    1. Grant of RSUs.

    In consideration of services rendered to the Company by the Participant, the Company has granted to
        the Participant, subject to the terms and conditions set forth herein and in the Company’s Stock Incentive Plan (the “Plan”), an award of Restricted Stock
        Units (the “RSUs”), representing the number of RSUs set forth under your account in the Company’s third-party electronic stock administrative platform.  The
        RSUs entitle the Participant to receive, upon and subject to the vesting of the RSUs (as described in Section 2 below), one share of common stock, $0.001 par value per share, of the Company (the “Common Stock”) for each RSU that vests.  The shares of Common Stock that are issuable upon vesting of the RSUs are referred to herein as the “Shares.”

    The grant of RSUs under the Plan is made at the discretion of the Company and the Plan may be suspended or terminated by
        the Company at any time.

    

    

    The Company does not give any advice or any guarantee as to how the grant or vesting of the RSUs will be taxed and the
        Participant should consult an independent financial adviser in that respect.

    

    

    2. Vesting of RSUs and Issuance of Shares.

    (a) General.  Subject to the other provisions of this Section 2, the RSUs shall vest
        one-third per year over three years on the day immediately prior to the applicable anniversary of the grant date, in accordance with the future vesting schedule (the “Vesting
            Schedule”) set forth under your account in the Company’s third-party electronic stock administrative platform.  Subject to Section 4, as soon as administratively practicable after each vesting date shown in the Vesting Schedule (each
        a “Vesting Date”), the Company will issue to the Participant, in certificated or uncertificated form, such number of Shares as is equal to the number of RSUs
        that vested on such Vesting Date.  In no event shall the Shares be issued to the Participant later than 75 days after the Vesting Date.

    (b) Termination of Employment.  Except as set forth in Section 2(c) below, upon the
        cessation of the Participant’s employment with the Company for any reason, all unvested RSUs shall be automatically forfeited as of such cessation of employment.  For purposes of this UK RSU Award Agreement, employment with the Company shall
        include employment as an employee or director of the Company or to a parent or subsidiary of the Company, or any successor to the Company.

    (c) Change in Control Event.  Upon a Change in Control Event (as defined in the Plan), the
        RSUs shall be treated in the manner provided in Section 9(b)(iii)(B) of the Plan.

    

    

    

    

    3. Dividends.

    At the time of the issuance of Shares to the Participant pursuant to Section 2, the Company shall
        also pay to the Participant an amount of cash equal to the aggregate amount of all dividends paid by the Company, between the grant date and the issuance of such Shares, with respect to the number of Shares so issued to the Participant.

    4. UK Tax Obligations.

    (a) Tax Indemnity.  The Participant agrees to indemnify and keep indemnified his employing
        company (the “Employer”) and the Company from and against any liability for or obligation to pay any Tax Liability (a “Tax Liability” being any liability for income tax, employee’s National Insurance contributions and (at the discretion of the Company and where lawful) employer’s National Insurance
        Contributions (or other similar obligations to pay tax and social security wherever in the world arising) that is attributable to: (1) the grant or any benefit derived by Participant from, the RSUs or the Shares which are the subject of the RSUs;
        (2) the transfer or issue of Shares to Participant on vesting of the RSUs; (3) any restrictions applicable to the Shares held by the Participant ceasing to apply to those shares; or (4) the disposal of any Shares.

    (b) Tax Liability.  The Company will not issue any Shares on vesting until the Participant
        has made such arrangements as the Company may require for the satisfaction of any Tax Liability that may arise in connection with the vesting of the RSUs and/or the acquisition of the Shares by the Participant.  The Company shall not be required to
        issue, allot or transfer Shares until Participant has satisfied this obligation.

    (c) Election.  The Participant undertakes that upon request by the Company, he/she will (on or within 14 days acquiring the Shares) join with his Employer in electing, pursuant to Section 431(1) of the Income Tax (Earnings and Pensions)
        Act 2003 (“ITEPA”) that, for relevant tax purposes, the market value of the Shares acquired on vesting of the RSUs on any occasion will be calculated as if
        the Shares were not restricted and Sections 425 to 430 (inclusive) of ITEPA are not to apply to such Shares.

    (d) The Company has the right and option, but not the obligation, to treat the Participant’s failure to provide timely payment in accordance with the Plan of any withholding tax
        arising in connection with the RSUs as the Participant’s election to satisfy all or any portion of the withholding tax by requesting the Company repurchase Shares otherwise issuable under the Award limited to the number of Shares which have an
        aggregate fair market value on the date of repurchase necessary to pay the aggregate amount of Tax Liability.

    (e) The Participant acknowledges that the Participant is ultimately liable and responsible for all taxes owed in connection with the RSUs, regardless of any action the Company takes
        with respect to any tax withholding obligations that arise in connection with the RSUs. The Company does not make any representation or undertaking regarding the treatment of any tax withholding in connection with the awarding or vesting of the
        RSUs or the subsequent sale of Shares.  The Company does not commit and is under no obligation to structure the Award to reduce or eliminate the Participant’s Tax Liability.

    5.   Restrictions
            on Transfer.

    Neither the RSUs, nor any interest therein (including the right to receive dividend payments in
        accordance with Section 3), may be transferred by the Participant except to the extent specifically permitted in Section 10(a) of the Plan.

    6. Data Protection.

    (a) The Participant expressly acknowledges that the Company’s processing of his personal data is necessary:

    i. for the performance of this UK RSU Award Agreement;

    ii. for the legitimate interests of the Company (which includes all the interests noted in Section 6(b) (i)-(vi) below); and/or

    iii. to comply with the Company’s legal obligations in the UK and/or other EU member states in connection with: (a) the Participant’s employment; (b) any litigation, internal or
        regulatory investigation; or (c) as otherwise permitted by the Data Protection Act 1998 or by Regulation EU 2016/679 (the “GDPR”).

    (b) The Participant further acknowledges that the Company’s processing of his sensitive, or special categories of, personal data (which may include information relating to health,
        personal characteristics, criminal offences, allegations of criminal conduct and trade union membership) is necessary:

    i. to carry out its or their obligations to the Participant in the fields of employment, social security, and/or social protection;

    ii. for the purposes of preventative or occupational medicine, or the assessment of working capacity;

    iii. for statistical purposes and equal opportunities monitoring;

    iv. to administer its pensions and benefits schemes;

    v. in connection with the establishment, exercise or defence of legal claims; and/or

    vi. for reasons of substantial public interest, as further described in the Company’s data protection policy.

    (c) The processing may include disclosure of personal data and sensitive or special categories of personal data to third parties
        including benefit providers, prospective purchasers or service providers and governmental authorities.

    (d) A separate privacy notice has been provided in accordance with article 13 of the GDPR.

    (e) The Participant expressly acknowledges that the Company may transfer such data outside the European Economic Area (including,
        in particular, to offices in the United States) for such purposes and acknowledge that such countries may not have laws which adequately safeguard such data.

    7. Provisions of the Plan.

    This UK RSU Award Agreement is subject to the provisions of the Plan. The Participant acknowledges
        receipt of the Plan, along with the Prospectus relating to the Plan.

    8. Section 409A.

    This UK RSU Award Agreement is intended to comply with or be exempt from Section 409A of the U.S.
        Internal Revenue Code of 1986, as amended, and the guidance issued thereunder (“Section 409A”) and shall be interpreted and construed consistently
        therewith.  In no event shall either the Participant or the Company have the right to accelerate or defer delivery of the Shares to a date or event other than as set forth herein except to the extent specifically permitted or required by Section
        409A.  In the event that the Participant is a “specified employee” within the meaning of Section 409A and the Shares are to be delivered in connection with the termination of the Participant’s employment, the delivery of the Shares and any
        dividends payable under Section 3 in connection with such delivery shall be delayed until the date that is six months and one day following the date of the Participant’s termination of employment if required to avoid the imposition of additional
        taxes under Section 409A.  Solely for purposes of determining when the Shares (and any dividends payable under Section 3) may be delivered in connection with the Participant’s termination of employment, such termination of employment must
        constitute a “separation from service” within the meaning of Section 409A.

    9. Miscellaneous.

    (a) No Rights to Service.  The Participant acknowledges and agrees that the grant of the
        RSUs and their vesting pursuant to Section 2 do not constitute an express or implied promise of continued employment or service with the Company for the vesting period, or for any period.

    (b) Entire Agreement.  These terms and the Plan constitute the entire agreement between
        the parties, and supersede all prior agreements and understandings, relating to the subject matter of this UK RSU Award Agreement; provided that any separate employment, consulting or severance plan or agreement between the Company and the
        Participant that includes terms relating to the acceleration of vesting of equity awards shall not be superseded by these terms.

    (c) Acknowledgement. The Participant acknowledges that this UK RSU Award Agreement has not
        been issued and has not been approved by, an authorised person within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom and is being directed at the Participant because the offer to which this UK RSU Award Agreement
        relates has been determined as having regard to the Participant’s circumstances as an employee of the Company. This UK RSU Award Agreement is strictly confidential and is not for distribution to, and may not be acted upon by, any other person other
        than the person to whom it has been specifically addressed.

    (d) Governing Law.  This UK RSU Award Agreement shall be construed, interpreted and
        enforced in accordance with the internal laws of the State of Delaware without regard to any applicable conflict of law principles.

    (e) Interpretation.  The interpretation and construction of any terms or conditions of the
        Plan or this UK RSU Award Agreement by the Compensation Committee shall be final and conclusive.

    Signed by [●] [Company]

    ____________________________

    

    

    acting by [●]

    

    

    Date: ____________________________

    

    

    I hereby agree to accept the grant of the RSUs on and subject to the terms and conditions set out in the Plan and this UK
        RSU Award Agreement.

    

    

    ___________________________ ____________________________

    [●][Name] Date

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00292-of-00352.parquet"}]]